上海医药(601607.SH)：硫酸沙丁胺醇注射液通过仿制药一致性评价

智通财经2025-07-28

智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海禾丰制药有限公司(以下简称“上药禾丰”)的硫酸沙丁胺醇注射液收到国家药品监督管理局(“国家药监局”)颁发的《药品补充申请批准通知书》(通知书编号：2025B03280)，该药品通过仿制药质量和疗效一致性评价。根据国家相关政策，通过一致性评价的品种在医保支付及医疗机构采购等领域将获得更大的支持力度。因此上药禾丰的硫酸沙丁胺醇...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2554353724?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-28 16:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554353724","market":"sh","top_or_hot":-1,"title":"上海医药(601607.SH)：硫酸沙丁胺醇注射液通过仿制药一致性评价","media":"智通财经","content":"<div>\n<p>智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海禾丰制药有限公司(以下简称“上药禾丰”)的硫酸沙丁胺醇注射液收到国家药品监督管理局(“国家药监局”)颁发的《药品补充申请批准通知书》(通知书编号：2025B03280)，该药品通过仿制药质量和疗效一致性评价。根据国家相关政策，通过一致性评价的品种在医保支付及医疗机构采购等领域将获得更大的支持力度。因此上药禾丰的硫酸沙丁胺醇...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1322614.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>上海医药(601607.SH)：硫酸沙丁胺醇注射液通过仿制药一致性评价</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n上海医药(601607.SH)：硫酸沙丁胺醇注射液通过仿制药一致性评价\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-28 16:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1322614.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海禾丰制药有限公司(以下简称“上药禾丰”)的硫酸沙丁胺醇注射液收到国家药品监督管理局(“国家药监局”)颁发的《药品补充申请批准通知书》(通知书编号：2025B03280)，该药品通过仿制药质量和疗效一致性评价。根据国家相关政策，通过一致性评价的品种在医保支付及医疗机构采购等领域将获得更大的支持力度。因此上药禾丰的硫酸沙丁胺醇...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1322614.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0183","symbol_name":"MSCI概念","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1322614.html","article_id":"2554353724","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554353724","pubTimestamp":1753692963,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海禾丰制药有限公司(以下简称“上药禾丰”)的硫酸沙丁胺醇注射液收到国家药品监督管理局(“国家药监局”)颁发的《药品补充申请批准通知书》(通知书编号：2025B03280)，该药品通过仿制药质量和疗效一致性评价。根据国家相关政策，通过一致性评价的品种在医保支付及医疗机构采购等领域将获得更大的支持力度。因此上药禾丰的硫酸沙丁胺醇注射液通过仿制药一致性评价，有利于扩大该药品的市场份额，提升市场竞争力，同时为公司后续产品开展一致性评价工作积累了宝贵的经验。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"601607":"上海医药","BK0183":"MSCI概念","BK0209":"零售","BK0188":"融资融券","BK0020":"浦东新区","BK0012":"证金概念","BK0097":"医药电商","BK0175":"白马股","BK0196":"行业龙头","BK0187":"一线龙头","02607":"上海医药","BK0099":"上海本地重组","BK0184":"上海国资改革","BK0028":"国家队","BK1197":"保健护理产品经销商"},"translate_title":"Shanghai Pharmaceuticals (601607. SH): Salbutamol Sulfate Injection Passed Generic Drug Consistency Evaluation","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"02607":1},"content_text":"智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海禾丰制药有限公司(以下简称“上药禾丰”)的硫酸沙丁胺醇注射液收到国家药品监督管理局(“国家药监局”)颁发的《药品补充申请批准通知书》(通知书编号：2025B03280)，该药品通过仿制药质量和疗效一致性评价。根据国家相关政策，通过一致性评价的品种在医保支付及医疗机构采购等领域将获得更大的支持力度。因此上药禾丰的硫酸沙丁胺醇注射液通过仿制药一致性评价，有利于扩大该药品的市场份额，提升市场竞争力，同时为公司后续产品开展一致性评价工作积累了宝贵的经验。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2554353724","isCrawlerRequest":true}